The following are excerpts from the newsletter

November 29, 2012

  • Side tracks on the safety express
    Interruptions lead to errors and unfinished… Wait, what was I doing? 

  • Sterile compounding safety guidelines. ISMP has finalized the Proceedings from the ISMP Sterile Preparation Compounding Safety Summit: Guidelines for Safe Preparation of Sterile Compounds, which can be found at

  • Safety Brief: Insulin concentration rarely needed on orders. On a medication reconciliation form, someone entered U-100 strength for LANTUS (insulin glargine) instead of the dose under the “dosage” section. This could be mistaken as an insulin dose of 100 units when the patient actually takes 44 units of U-100 Lantus.

  • Safety Brief: Can chain pharmacy programs reduce readmissions? ISMP is interested in your input regarding the perceived advantages and disadvantages regarding internal and external hospital-community liaison programs. To access the survey, go to: Please complete the survey by December 21.

  • Your Reports at Work. USP updates heparin label to display the strength per total volume as the primary expression, followed closely by the strength per mL in parenthesis.

  • ISMP webinar. Join us on December 18, for our last webinar of the year, Improving Medication Safety Through Staff Education and Competency Assessment: An Important Challenge for Healthcare Organizations. For details, please visit

Acute Care Main Page
Current Issue
Past Issues
Highlighted articles
Action Agendas
  - Free Nursing CEs
Special Alerts
Group Purchasing Subscription
Newsletter Editions
Acute Care
Community/Ambulatory Care
Nurse AdviseERR
Long-Term Care AdviseERR
Safe Medicine
Home | Contact UsEmployment  |   Legal Notices | Privacy Policy | Help Support ISMP
 Med-ERRS | Medication Safety Officer Society Medication Safety Officers Society | Consumer Medication Safety For consumers
ISMP Canada | ISMP Spain  | ISMP Brasil  | International Group  | Pennsylvania Patient Safety Authority

200 Lakeside Drive, Suite 200, Horsham, PA 19044, Phone: (215) 947-7797,  Fax: (215) 914-1492
© 2018 Institute for Safe Medication Practices. All rights reserved